Washington University in St. Louis is included in a report released Sept. 7 by the National Academy of Inventors (NAI) and the Intellectual Property Owners Association, ranking it among the top 100 universities worldwide granted U.S. patents in 2020.
John F. DiPersio, MD, PhD is a leader in developing novel therapies for leukemia and in understanding how such therapies work.
Polina V. Lishko co-founded the startup company YourChoice Therapeutics. While she has since stepped away from the company, YourChoice Therapeutics continues to build on her research to develop temporary, nonhormonal contraceptives.
Richard Axelbaum, PhD, at the McKelvey School of Engineering, along with five researchers at the School of Medicine — David T. Curiel, MD, PhD; James W. Janetka, PhD; Gregory M. Lanza, MD, PhD; Robi D. Mitra, PhD; and Jennifer N. Silva, MD — are being recognized for their success in patents, licensing and commercialization, and for producing technologies that have the potential to have a significant impact on the welfare of society.
In coming to St. Louis, Vir joins a vibrant immunobiology and microbiology research community, which includes world leaders in the study of alternatives to antibiotics for bacterial infections; infections and inflammation in the brain; and the wide-ranging influence of the gut microbiome – the community of bacteria in our digestive tracts – on health and disease.
The NAI fellowship is the highest professional distinction reserved solely for academic inventors.
In his new role, Dedric Carter will provide vision and strategy to advance the culture of innovation across the university, strengthen intellectual property assets for licensing, and identify new ventures and opportunities in the entrepreneurial ecosystem.
A new report released by the National Academy of Inventors (NAI) and the Intellectual Property Owners Association includes Washington University in St. Louis among the top 100 universities worldwide granted U.S. patents in 2020.